Eisler Capital (Uk) Ltd. Eli Lilly & CO Put Options Transaction History

Eisler Capital (Uk) Ltd.

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $28.6 Million - $35.5 Million	37,024 Added 23.75%	192,894 $171 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $39.8 Million - $50 Million	54,961 Added 54.47%	155,870 $141 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $14.9 Million - $19.9 Million	25,087 Added 33.09%	100,909 $78.5 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $24.4 Million - $28.7 Million	46,382 Added 157.55%	75,822 $44.2 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $11.5 Million - $15.9 Million	26,540 Added 915.17%	29,440 $15.8 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $1.02 Million - $1.36 Million	2,900 New	2,900 $1.36 Million

4,003

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.